Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 20 of 20 entries
View as:

The Impact of Intervention With High-protein Enteral Formula in SICU.

Phase: N/A Priority: Normal
NCT ID: NCT04868318 Org: User:
Start: 05/10/21 End: 12/31/21 Due: 12/31/22

Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines

Phase: N/A Priority: Normal
NCT ID: NCT02799719 Org: User:
Start: 03/31/14 End: 12/31/16 Due: 12/31/17

Serum Level of Myokines and Protein Energy Wasting, Inflammation and Atherosclerosis in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02718586 Org: User:
Start: 03/31/16 End: 12/31/16 Due: 12/31/17

Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT05752968 Org: User:
Start: 05/03/23 End: 12/31/23 Due: 12/31/24

Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation

Phase: N/A Priority: Normal
NCT ID: NCT01458652 Org: User:
Start: 01/31/11 End: 10/31/13 Due: 10/31/14

Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06211244 Org: User:
Start: 05/02/24 End: 12/31/24 Due: 12/31/25

Serum YKL-40 Levels is Associated With Nutritional and Oxidative Status of Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06206694 Org: User:
Start: 05/02/24 End: 12/31/24 Due: 12/31/25

Association Between Fecal Microbiota Composition, Metabolite Concentrations, and Indoxyl Sulfate Levels

Phase: N/A Priority: Normal
NCT ID: NCT06877585 Org: User:
Start: 04/01/25 End: 12/31/25 Due: 12/31/26

Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT00431249 Org: User:
Start: 02/28/07 End: 04/30/08 Due: 04/30/09

Roles of Uremic Toxins in Uremic Sacropenia

Phase: N/A Priority: Normal
NCT ID: NCT03060590 Org: User:
Start: 04/01/17 End: 01/31/20 Due: 01/31/21

Association of Uremic Sarcopenia and Mitochondrial Copy Number and Its Clinical Correlates

Phase: N/A Priority: Normal
NCT ID: NCT03929458 Org: User:
Start: 05/07/19 End: 12/31/19 Due: 12/31/20

Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03427307 Org: User:
Start: 06/03/18 End: 01/31/21 Due: 01/31/22

Constipation, Gut Microbiome, and Microbial-derived Uremic Toxins From the Gut Microbiota in HD Patients

Phase: N/A Priority: Normal
NCT ID: NCT04309019 Org: User:
Start: 03/10/20 End: 12/31/20 Due: 12/31/21

Insulin Resistance, Sarcopenia and Plasma BAIBA Levels

Phase: N/A Priority: Normal
NCT ID: NCT04309201 Org: User:
Start: 03/10/20 End: 12/31/20 Due: 12/31/21

Association of Constipation Inflammatory and Microbial Translocation Markers

Phase: N/A Priority: Normal
NCT ID: NCT04307121 Org: User:
Start: 03/10/20 End: 12/31/20 Due: 12/31/21

Correlation Between Autophagy-related Proteins and Inflammatory Markers in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03925753 Org: User:
Start: 03/01/19 End: 12/31/19 Due: 12/31/20

Comparison of Post- and Pre-dilutional Hemodiafiltration in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03288285 Org: User:
Start: 09/01/17 End: 04/07/19 Due: 04/07/20

Cardiac Biomarkers and Iron Status in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT05256004 Org: User:
Start: 06/01/22 End: 12/31/22 Due: 12/31/23

Thrombospondin-4 Levels and Peripheral Arterial Disease in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04735562 Org: User:
Start: 04/01/21 End: 12/31/21 Due: 12/31/22

Prevalence and Determinants of Sarcopenic Obesity in Taiwanese Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02718612 Org: User:
Start: 03/31/16 End: 12/31/16 Due: 12/31/17